Earnings Call
Apr 21, 2026
Q1 FY2026
EPS Estimate
6.58
EPS Actual
7.23
Post-Earnings Close
$346.01
Earnings Reaction
+7.0%
UnitedHealth Group's Q1 2026 results delivered a meaningful positive surprise, with adjusted EPS of $7.23 coming in well ahead of both the consensus estimate of $6.58 and management's own internal plan. Total revenues of $111.7 billion grew 2% year-over-year, also beating expectations, and all four operating segments exceeded plan, a notable inflection after a period of persistent misses and guidance cuts that had eroded investor confidence. The medical care ratio of 83.9% improved 90 basis points from Q1 2025's 84.8%, driven by pricing discipline, favorable reserve development of approximately $500 million net, and lower-than-expected respiratory activity. Management was careful to flag that these seasonal tailwinds will moderate in Q2, and that the MCR is expected to run more than 250 basis points higher in the second half relative to first-half levels, a meaningful earnings cadence dynamic investors must internalize.
Report generated on Apr 22, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full UNH analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.